Home » Topics » Conferences

Conferences
RSS

Combination of FTY-720 and ciclosporin inhibits pig islet xenograft rejection in rats

Nov. 3, 1999

Prucalopride dramatically improves symptoms in patients with chronic constipation

Nov. 3, 1999

MCC-135 restores impaired Ca2+-ATPase activity in the postischemic myocardium

Nov. 3, 1999

Rock/Rho kinase inhibitor Y-27632: a promising vasodilator for treatment of heart failure

Nov. 3, 1999

Celecoxib in FAP: results of clinical trial discussed at ACG

Nov. 2, 1999

Candidate treatment for atopic dermatitis presented at Japanese congress

Nov. 2, 1999

CGS-35066: potent and specific ECE inhibitor presented at ET-6

Nov. 2, 1999

Abbott's ETA antagonist may also be indicated for diabetic nephropathy

Oct. 29, 1999

ETA/ETB antagonist tezosentan is a promising parenteral treatment for acute conditions

Oct. 29, 1999

Hydroxyurea tested as an alternative to PI in combination regimens in antiretroviral-naive subjects

Oct. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...